Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Decred Price Eyes $23 as Growing On-Chain Activity Meets Key Technical Barrier

Decred Price Eyes $23 as Growing On-Chain Activity Meets Key Technical Barrier

CoinpediaCoinpedia2026/07/13 19:48
By:Coinpedia
Story Highlights
  • Decred's on-chain activity is improving through stronger transaction volume and network engagement.

  • Price rebounded from the major $11 support and recently retested the $16 region.

  • A breakout above the 50-day EMA could open upside targets at $23, $33 and $49.

Decred price is starting to show signs of life after spending months under pressure, but the real test hasn’t arrived just yet. While the broader market continues hunting for stronger narratives, Decred’s improving on-chain activity is quietly building a case that something may be changing beneath the surface.

The network is recording healthier blockchain usage, even as the token continues battling a major technical resistance level. Whether that translates into a sustained rally now depends on one thing buyers haven’t fully delivered yet and that is follow-through.

Decred Network Activity Starts Moving Higher Again

Decred Price Eyes $23 as Growing On-Chain Activity Meets Key Technical Barrier image 0

Under the hood, Decred’s blockchain is showing encouraging signals. Recent on-chain data points to rising network utility, supported by healthy median daily transaction amounts per block and noticeable structural changes in block generation periods.

Together, these metrics suggest transaction volume and user engagement are gradually expanding. While price hasn’t fully reflected that improvement yet, strengthening network activity often provides a stronger fundamental backdrop than price action alone.

Decred Price Eyes $23 as Growing On-Chain Activity Meets Key Technical Barrier image 1

Even so, improving fundamentals don’t automatically guarantee upside. Markets have a habit of demanding both utility and sustained buying demand before rewarding an asset.

Decred Price Faces Critical Technical Test

Price action has already responded positively from a historically important support zone near $11, where buyers stepped in aggressively. That defense fueled a sharp intraday recovery toward $16, indicating renewed bullish interest at lower valuation levels.

Now comes the difficult part. Decred price is trading directly beneath the 50-day Exponential Moving Average (EMA), which currently serves as immediate overhead resistance. A decisive close above this moving average would strengthen the bullish structure and open the path toward the first technical target around $23.

If buying momentum continues building beyond that level, broader expansion targets near $33 and $49 become the next major technical zones to watch.

Decred Price Eyes $23 as Growing On-Chain Activity Meets Key Technical Barrier image 2

Demand Remains The Missing Ingredient

Despite improving network metrics and strengthening price structure, Loading profile preview still lacks a widely recognized catalyst capable of attracting significant retail or institutional attention.

Without fresh demand, the current setup could lose momentum. If buyers fail to maintain support, the asset risks falling back below the critical $11 level, exposing Decred to renewed downside pressure and potentially opening the door to fresh all-time lows.

For now, Decred price sits at an important crossroads where improving blockchain fundamentals are colliding with a decisive technical resistance.

  • Decred Price Eyes $23 as Growing On-Chain Activity Meets Key Technical Barrier image 3
    DCR
    $ 12.40
    (9.86%)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market